Total Holdings
69
Portfolio diversification across 69 positions
IBRN
(NYSEARCA)iShares Neuroscience and Healthcare ETF
$31.94-- (--)
Loading... - Market loading
IBRN ETF Holdings: iShares Neuroscience and Healthcare ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$4.95M
Total fund assets
Expense Ratio
0.47%
Annual management fee
Fund Issuer
BlackRock
NYSEARCA
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 50 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Praxis Precision Medicines, Inc | Stock | 5.22% |
| 2 |  | Axsome Therapeutics, Inc. | Stock | 5.00% |
| 3 |  | Alkermes plc | Stock | 4.69% |
| 4 |  | PTC Therapeutics, Inc | Stock | 4.68% |
| 5 |  | Scholar Rock Holding Corp | Stock | 4.47% |
| 6 |  | Biogen Inc | Stock | 4.38% |
| 7 |  | argenx SE | Stock | 3.76% |
| 8 |  | Xenon Pharmaceuticals Inc | Stock | 3.74% |
| 9 |  | Catalyst Pharmaceuticals Inc | Stock | 3.73% |
| 10 |  | Supernus Pharmaceuticals, Inc. | Stock | 3.67% |
| 11 |  | Neurocrine Biosciences, Inc. | Stock | 3.66% |
| 12 |  | Denali Therapeutics Inc. | Stock | 3.55% |
| 13 |  | ACADIA Pharmaceuticals Inc. | Stock | 3.53% |
| 14 |  | Dyne Therapeutics Inc | Stock | 3.25% |
| 15 |  | Centessa Pharmaceuticals plc | Stock | 3.09% |
| 16 | K KRX:326030 | SK Biopharmaceuticals Co., Ltd. | Stock | 2.91% |
| 17 |  | Edgewise Therapeutics, Inc. | Stock | 2.84% |
| 18 |  | Sarepta Therapeutics, Inc | Stock | 2.82% |
| 19 |  | Avadel Pharmaceuticals plc | Stock | 2.82% |
| 20 |  | Dianthus Therapeutics, Inc. | Stock | 2.23% |
| 21 | H HLUNB.CO | H. LUNDBECK CLASS B | Stock | 2.13% |
| 22 |  | Axogen, Inc. | Stock | 2.08% |
| 23 | S ST:BIOA.B | BioArctic AB (publ) | Stock | 1.89% |
| 24 | S STO:BIOA.B | BioArctic AB (publ) | Stock | 1.79% |
| 25 |  | Biohaven Ltd. | Stock | 1.59% |
| 26 | S ST:DYVOX | Dynavox Group | Stock | 1.47% |
| 27 | S STO:DYVOX | Dynavox Group AB (publ) | Stock | 1.42% |
| 28 |  | Taysha Gene Therapies, Inc | Stock | 1.32% |
| 29 |  | Integra LifeSciences Holdings Corporation | Stock | 1.27% |
| 30 | T TSE:4592 | Sanbio Company Limited | Stock | 0.87% |
| 31 |  | REGENXBIO Inc | Stock | 0.82% |
| 32 | H HKG:2190 | Zylox-Tonbridge Med Tech Co | Stock | 0.81% |
| 33 |  | Bright Minds Biosciences Inc | Stock | 0.73% |
| 34 |  | Rapport Therapeutics, Inc. Common Stock | Stock | 0.69% |
| 35 |  | Prothena Corporation plc | Stock | 0.66% |
| 36 |  | Fulcrum Therapeutics Inc | Stock | 0.63% |
| 37 |  | Annexon Inc | Stock | 0.57% |
| 38 |  | Neuropace Inc | Stock | 0.55% |
| 39 |  | CBLL | Stock | 0.50% |
| 40 | H HKG:2172 | MicroPort NeuroTech Ltd | Stock | 0.48% |
| 41 |  | ClearPoint Neuro Inc | Stock | 0.48% |
| 42 | H HKG:9996 | Peijia Medical Ltd | Stock | 0.47% |
| 43 |  | Anavex Life Sciences Corp | Stock | 0.45% |
| 44 |  | Solid Biosciences Inc | Stock | 0.44% |
| 45 |  | Benitec Biopharma Inc | Stock | 0.42% |
| 46 |  | Vanda Pharmaceuticals Inc | Stock | 0.40% |
| 47 |  | Capricor Therapeutics Inc | Stock | 0.37% |
| 48 |  | Neurogene Inc | Stock | 0.34% |
| 49 |  | Entrada Therapeutics Inc | Stock | 0.32% |
| 50 |  | Voyager Therapeutics, Inc | Stock | 0.25% |